Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Internal and Emergency Medicine|May 24, 2020
Does this patient have COVID-19? A practical guide for the internistLorenzo Bertolino, Martina Vitrone, Emanuele Durante-MangoniClinics and Practice|May 2, 2017
Infection of Retained Defibrillator Lead Fragment after Heart TransplantEmanuele Durante-Mangoni, Martina Vitrone, Irene Mattucci, et al.Journal of Chemotherapy (Florence, Italy)|September 20, 2017
Can we go for a shorter treatment course in chronic hepatitis C? More inspiring casesRosa Zampino, Martina Vitrone, Antonio Parrella, et al.Journal of Chemotherapy (Florence, Italy)|February 21, 2019
Dynamics and management of oral anticoagulant treatment in chronic hepatitis C patients undergoing therapy with direct antiviral agentsMartina Vitrone, Antonio Parrella, Rosina Albisinni, et al.Clinical Transplantation|April 24, 2019
Hepatitis B core-related antigen to detect hepatitis B virus (HBV) reactivation in heart transplant recipients with past HBV infection: A pilot studyDomenico Iossa, Martina Vitrone, Antonietta Liotti, et al.Annals of Translational Medicine|February 8, 2021
Anthropometric parameters and liver histology influence lipid metabolic changes in HCV chronic hepatitis on direct-acting antiviral treatmentDomenico Iossa, Martina Vitrone, Massimo Gagliardi, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 16, 2017
Direct antiviral treatment of chronic hepatitis C in heart transplant recipientsMartina Vitrone, Roberto Andini, Irene Mattucci, et al.Journal of Clinical Pharmacology|January 25, 2017
Electrophysiological Adverse Effects of Direct Acting Antivirals in Patients With Chronic Hepatitis CEmanuele Durante-Mangoni, Antonio Parrella, Martina Vitrone, et al.Internal and Emergency Medicine|January 29, 2019
Liver histopathological findings in advanced heart failure: a reappraisal of cardiac cirrhosis conceptEmanuele Durante-Mangoni, Antonio Parrella, Pia Clara Pafundi, et al.Antiviral Therapy|March 6, 2018
HCV genotype-3h, a difficult-to-diagnose sub-genotype in the DAA eraCarmine Minichini, Mario Starace, Stefania De Pascalis, et al.Pageof 2